Affiliation:
1. Hind Institute of Medical Sciences, Uttar, Pradesh, India
Abstract
The most dreaded sickness to have lately spread across the world is thought to be corona virus disease 2019 (COVID-19). During the first wave, India had extremely few COVID-19-positive cases per million people, but during the second wave, even more than 400,000 confirmed cases/day were reported. News of the medical oxygen shortage became more widely publicised following the Corona virus pandemic epidemic (Covid-19). One of the most crucial elements in the care of patients who have Covid-19 is medical oxygen. When the Covid epidemic was at its worst, India's medical system struggled with an oxygen shortage, which caused a sharp increase in the daily death toll. The demand for oxygen cylinders, ventilators, and other medical supplies grew to the point that there was not enough supply (availability). There was a significant unmet demand as a result. The Government of India made several attempts to fast ramp up the production process in order to guarantee that medical oxygen is given to individuals who are in dire need of it. However, the medical oxygen was unable to be transported from the point of production to the point of consumption due to significant logistical and supply chain issues. The goal of this study article is to thoroughly comprehend the numerous factors that contributed to the medical oxygen system failing in India during the second wave of the Covid-19 virus.
Publisher
IP Innovative Publication Pvt Ltd
Reference20 articles.
1. Andrews M, Areekal B, Rajesh K, Krishnan J, Suryakala R, Krishnan B, Muraly C, Santhosh P, First Confirmed Case of COVID-19 Infection in India: A Case Report.Indian J. Med. Res ;2020:490-490
2. Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S, Emergence of Novel Coronavirus and COVID-19: Whether to Stay or Die Out?.Crit Rev Microbiol 2020;46(2):182-93
3. Forni D, Cagliani R, Clerici M, Sironi M, Molecular Evolution of Human Coronavirus Genomes.Trends Microbiol 2017;25(1):35-48
4. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing.Nature 2020;583:459-68
5. Huang Y, Yang C, Xu X, Xu W, Liu S, Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19.Acta Pharmacol Sin 2020;41:1141-9